You are viewing an incomplete version of our website. Please click to reload the website as full version.

Aperçu des produits pour anti-BCL2 (BCL2) Anticorps

Full name:
anti-B-Cell CLL/lymphoma 2 Anticorps (BCL2)
Chez sont 1075 B-Cell CLL/lymphoma 2 (BCL2) Anticorps de 37 de différents fournisseurs disponibles. De plus, nous expédions BCL2 Kits (50) et BCL2 Protéines (18) et beaucoup plus de produits pour cette protéine. Un total de 1176 BCL2 produits sont actuellement listés.
AW986256, bcl-2, Bcl2, C430015F12Rik, D630044D05Rik, D830018M01Rik, PPP1R50

Réactivités les plus populaires pour anti-BCL2 (BCL2) Anticorps

Sélectionnez vos espèces et l'application

anti-Mouse (Murine) BCL2 Anticorps:

anti-Human BCL2 Anticorps:

anti-Rat (Rattus) BCL2 Anticorps:

Tous anti-BCL2 Anticorps disponible

Vous arrivez à notre recherche pré-filtrée.

anti-BCL2 Anticorps mieux référencés

  1. Human Polyclonal BCL2 Primary Antibody pour IF, IHC (p) - ABIN388095 : Zheng, Zhou, Ye, Li, Bai, Zhang: The conformation change of Bcl-2 is involved in arsenic trioxide-induced apoptosis and inhibition of proliferation in SGC7901 human gastric cancer cells. dans World journal of surgical oncology 2010 (PubMed)
    Show all 19 references for ABIN388095

  2. Human Monoclonal BCL2 Primary Antibody pour FACS, IHC (fro) - ABIN118990 : Hockenbery, Nuñez, Milliman, Schreiber, Korsmeyer: Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. dans Nature 1991 (PubMed)
    Show all 4 references for ABIN118990

  3. Human Monoclonal BCL2 Primary Antibody pour FACS, WB - ABIN1105506 : Gallatin, Weissman, Butcher: A cell-surface molecule involved in organ-specific homing of lymphocytes. 1983. dans Journal of immunology (Baltimore, Md. : 1950) 2006 (PubMed)
    Show all 2 references for ABIN1105506

  4. Human Monoclonal BCL2 Primary Antibody pour IHC (fro), IF - ABIN1105504 : Ngan, Chen-Levy, Weiss, Warnke, Cleary: Expression in non-Hodgkin's lymphoma of the bcl-2 protein associated with the t(14;18) chromosomal translocation. dans The New England journal of medicine 1988 (PubMed)
    Show all 2 references for ABIN1105504

  5. Human Monoclonal BCL2 Primary Antibody pour FACS - ABIN1105508 : Tanaka, Yoshimi, Maeyama, Hagimoto, Kuwano, Hara: Resistance to Fas-mediated apoptosis in human lung fibroblast. dans The European respiratory journal 2002 (PubMed)
    Show all 2 references for ABIN1105508

  6. Human Polyclonal BCL2 Primary Antibody pour IHC, ELISA - ABIN1531302 : Cleary, Smith, Sklar: Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation. dans Cell 1986 (PubMed)

  7. Human Polyclonal BCL2 Primary Antibody pour WB - ABIN657744 : Feng, Stachura, White, Gutierrez, Zhang, Sanda, Jette, Testa, Neuberg, Langenau, Kutok, Zon, Traver, Fleming, Kanki, Look: T-lymphoblastic lymphoma cells express high levels of BCL2, S1P1, and ICAM1, leading to a blockade of tumor cell intravasation. dans Cancer cell 2010 (PubMed)

  8. Human Polyclonal BCL2 Primary Antibody pour EIA, IHC (p) - ABIN356812 : Liu, Zhou, Li, Sun, Lin, Lang, He, Cao, Yan, Wang, Lu, Han, Cao, Zhang, Zeng: Modulation of orphan nuclear receptor Nur77-mediated apoptotic pathway by acetylshikonin and analogues. dans Cancer research 2008 (PubMed)

  9. Human Polyclonal BCL2 Primary Antibody pour IHC, WB - ABIN2792106 : Chen, Valencia, Zhong, McColl, Roderick, Bootman, Berridge, Conway, Holmes, Mignery, Velez, Distelhorst: Bcl-2 functionally interacts with inositol 1,4,5-trisphosphate receptors to regulate calcium release from the ER in response to inositol 1,4,5-trisphosphate. dans The Journal of cell biology 2004 (PubMed)

Plus d’anticorps contre BCL2 partenaires d’interaction

Mouse (Murine) B-Cell CLL/lymphoma 2 (BCL2) interaction partners

  1. The abnormal expression of epidermal cytokeratins suggests that Ha-Ras and Bcl-2 suppress the terminal differentiation and sustain the stem cell-like features in epidermal keratinocytes

  2. the augmentation of endogenous MTA1 (Montrer MTA1 Anticorps) expression during neuronal ischemic injury acts additionally to an endocrinous cascade orchestrating intimate interactions between ERalpha (Montrer ESR1 Anticorps) and BCL2 pathways.

  3. Interestingly, SKPs showed higher protein levels of Bcl-2, Nrf2 (Montrer NFE2L2 Anticorps), and HO-1 (Montrer HMOX1 Anticorps) than FBs (Montrer FBS Anticorps). SKPs exert a beneficial effect on resisting UVB-induced apoptosis, which may be associated with Bcl-2 and Nrf2 (Montrer NFE2L2 Anticorps) upregulation.

  4. Bcl-2 is an essential regulator in the survival of doublecortin (Montrer DCX Anticorps)-expressing immature neurons.

  5. Results show that the deletion of BCL-2, on its own or in concert with MCL-1 (Montrer MCL1 Anticorps), does not affect platelet production or platelet lifespan.

  6. the expression changes observed within the BCL2 family did not depend on STAT3 (Montrer STAT3 Anticorps) signalling, in line with its initiating role early in the process, but rather appear to result from relief of repression by STAT5 (Montrer STAT5A Anticorps).

  7. Bcl-2-caspase-9 (Montrer CASP9 Anticorps) apoptosis pathway was clearly activated in the testis of asthmatic mice with the increased expression of apoptosis-related proteins.

  8. Bcl-2 expression in the endothelium plays a significant role during postnatal retinal vascularization, and pathological choroidal but not retinal neovascularization, suggesting vascular bed specific Bcl-2 function in the endothelium

  9. Studied the protein expression of BCL2, FGF-R1, and HSP70 (Montrer HSP70 Anticorps) after short-time magnetic thermoablative tumor treatment using immunohistochemistry in a human BT474 breast cancer mouse xenograft model.

  10. The increased level of Bcl-2 caused by the decrease in miR (Montrer MLXIP Anticorps)-181c protected mitochondrial morphology from the tumour necrosis factor alpha (Montrer TNF Anticorps)-induced apoptosis.

Guinea Pig B-Cell CLL/lymphoma 2 (BCL2) interaction partners

  1. bcl-2 and bax (Montrer BAX Anticorps) were expressed strongly in denervated guinea-pig facial muscle. [bcl-2; bax (Montrer BAX Anticorps)]

Human B-Cell CLL/lymphoma 2 (BCL2) interaction partners

  1. in addition to MCL-1 (Montrer MCL1 Anticorps), BCL-XL (Montrer BCL2L1 Anticorps) is heterogeneously expressed in HMCLs and patient samples. The expression profile of BCL-XL (Montrer BCL2L1 Anticorps) relative to BCL-2 and MCL-1 (Montrer MCL1 Anticorps) may be an important predictor of response to venetoclax sensitivity as a monotherapy and in combination with bortezomib.

  2. Data show that ATPase (Montrer DNAH8 Anticorps), calcium transporting, plasma membrane 2 protein (PMCA2 (Montrer ATP2B2 Anticorps)) silencing augmented B-cell leukemia 2 family proteins (Bcl-2) inhibitor ABT-263-mediated MDA-MB-231 breast cancer cell death.

  3. Bcl-2 expression patterns in various differentiated esophageal squamous cell carcinoma were higher than those in corresponding normal esophageal tissues with no statistical differences ( p > 0.05). Importantly, Bit1 (Montrer PTRH2 Anticorps) expression was positively correlated with both matrix metalloproteinase 2 (Montrer MMP2 Anticorps) and Bcl-2 expression in esophageal squamous cell carcinoma and esophageal adenocarcinoma tissues ( p < 0.05).

  4. The study supports the association of SNP rs1006737 with bipolar disorder-I (BD-I) and suggests that CACNA1C SNP rs1006737 and Bcl-2 SNP rs956572, or specific causal variants in linkage disequilibrium with these proxies, act independently to increase risk and Intracellular Ca(2+) dyshomeostasis (ICDH) in BD-I.

  5. The results suggest that miR125b may regulate the sensitivity of nasopharyngeal carcinoma cells to cisplatin by modulating the expression levels of antiapoptotic factor Bcl-2.

  6. Rhaponticum carthamoides extracts from transformed and normal roots increased the ratio of Bax (Montrer BAX Anticorps)/Bcl-2 proteins and increased TP53 (Montrer TP53 Anticorps) levels to reduce glioma cell proliferation.

  7. Data identified two, BCL2 and FAM19A2 (Montrer FAM19A2 Anticorps), novel loci and replicated known variants associated with insulin (Montrer INS Anticorps) sensitivity. Further studies are needed to clarify the causal variant and function at the BCL2 and FAM19A2 (Montrer FAM19A2 Anticorps) loci.

  8. PCNA (Montrer PCNA Anticorps), bcl-2 protein, and cyclin D1 (Montrer CCND1 Anticorps) expressions could be useful in evaluating the proliferative activity of the tumor and the aggressiveness of the clinical presentation

  9. Significantly suppresses the p-STAT3 (Montrer STAT3 Anticorps) expression and its downstream genes including CCL2 (Montrer CCL2 Anticorps) and Bcl2.

  10. the results of the present study indicated that PCDHGA3 (Montrer PCDHgA3 Anticorps) was expressed in follicular lymphoma(FL) irrespective of BCL2 status and grading and was associated with cell proliferation. Further studies involving molecular genetic analyses are required to elucidate the mechanisms underlying the activity of PCDHGA3 (Montrer PCDHgA3 Anticorps) in FL.

Cow (Bovine) B-Cell CLL/lymphoma 2 (BCL2) interaction partners

  1. Over-expression of STC-1 (Montrer STC1 Anticorps) up-regulated Bcl-2 protein expression and slightly down-regulated caspase-3 (Montrer CASP3 Anticorps) production in the damaged cells. Findings from this study suggest that STC-1 (Montrer STC1 Anticorps) plays a protective role in intestinal cells through an antioxidant mechanism.

  2. BoHV-5 replication apparently modulates BCL-2 expression and gene transcription, enhancing production of virus progeny, but does not increase Bax (Montrer BAX Anticorps) expression.

  3. G3139, a BCL-2 antisesnse oligonucleotide is a promising candidate for treatment of patients with imatinib-resistant Ph-positive leukemia.

  4. role of vascular endothelial growth factor receptor-1 (Montrer FLT1 Anticorps) in Bcl-2 expression

  5. apoptosis-inducing factor (Montrer AIFM1 Anticorps) was expressed in luminal alveolar cells and, in concert with a change in bax (Montrer BAX Anticorps) protein to bcl-2 protein ratio, might contribute to signalling of a change in the dynamic balance of the cell population as lactation progresses

  6. mRNA expression of Bax (Montrer BAX Anticorps), Bcl-2, caspase-3 (Montrer CASP3 Anticorps) and-7 cannot be used as a reliable apoptosis detection method.

  7. These results propose an additional mechanism whereby resveratrol may exert its cardioprotective effects and suggest a key role for Bcl-2 in the resveratrol anti-apoptotic action, especially in disrupting peroxynitrite-triggered mitochondrial pathway.

Rabbit B-Cell CLL/lymphoma 2 (BCL2) interaction partners

  1. excessive apoptosis does occur in acetabular cartilage with developmental dislocations of the hip, and is positively correlated with high caspase-3 (Montrer CASP3 Anticorps) expression as well as low Bcl-2 expression.

  2. These results indicate that RI-PostC can ameliorate myocardial ischemia-reperfusion injury and increase the Bcl-2/Bax (Montrer BAX Anticorps) ratio through a mechanism involving protein kinase C (Montrer PKC Anticorps).

  3. Cinobufagin can remarkably inhibit the proliferation and induce the apoptosis of lens epithelial cells by increasing expression of bax (Montrer BAX Anticorps) and decreasing expression of bcl2.

  4. Elevated local temperature of the testis buried in the inguinal pocket increases the apoptosis of spermatogenic cells, and the spermatogenic cell apoptosis is highly correlated with the decreased expression of Bcl-2 and increased expression of Bax (Montrer BAX Anticorps).

  5. Our data indicate that exposure to rabbits to Pb(Ac)(2) caused a significant increase of apoptosis protein p53 (Montrer TP53 Anticorps) and decrease in the antiapoptotic BCl2 proteins.

  6. Isoflurane delayed preconditioning can inhibit the apoptosis of myocardium by up-regulating the expression of Bcl-2 and down-regulating the activation of caspase-3 (Montrer CASP3 Anticorps).

  7. Data show that the damaged electron transport chain leads to bcl-2 depletion and MPT opening.

Zebrafish B-Cell CLL/lymphoma 2 (BCL2) interaction partners

  1. These results suggest a role for mitochondrial p53 (Montrer TP53 Anticorps) activity in promoting hair cell death due to aminoglycosides, likely upstream of Bax (Montrer BAX Anticorps) and Bcl2.

  2. Zebrafish gene expressions of P53 (Montrer TP53 Anticorps), Bcl-2, Bax (Montrer BAX Anticorps) and caspase-3 (Montrer CASP3 Anticorps) were elevated after exposure with microcystin-LR under different ambient temperatures.

  3. Analysis using clinical biopsy specimens revealed autophagy and increased levels of BCL2, S1P1 (Montrer S1PR1 Anticorps), and ICAM1 (Montrer ICAM1 Anticorps) in human T-lymphoblastic lymphoma compared with T-lymphoblastic leukemia.

  4. Real-time RT-PCR revealed acetaminophen treatment of zebrafish embryos decreased the expression of cox2 (Montrer COX2 Anticorps) and bcl2, but increased p53 (Montrer TP53 Anticorps) expression.

  5. Leukemia onset was dramatically accelerated in transgenic fish overexpressing human Notch1 (Montrer NOTCH1 Anticorps) and fish bcl-2, indicating synergy between the Notch (Montrer NOTCH1 Anticorps) pathway and the bcl2-mediated antiapoptotic pathway.

BCL2 profil antigène

Antigen Summary

This gene encodes an integral outer mitochondrial membrane protein that blocks the apoptotic death of some cells such as lymphocytes. Constitutive expression of BCL2, such as in the case of translocation of BCL2 to Ig heavy chain locus, is thought to be the cause of follicular lymphoma. Two transcript variants, produced by alternate splicing, differ in their C-terminal ends.

Alternative names and synonyms associated with BCL2

  • B-cell CLL/lymphoma 2 (BCL2) anticorps
  • B-cell CLL/lymphoma 2 (LOC100224888) anticorps
  • B cell leukemia/lymphoma 2 (Bcl2) anticorps
  • B-cell CLL/lymphoma 2 (Bcl2) anticorps
  • B-cell CLL/lymphoma 2 protein (BCL-2) anticorps
  • B-cell leukemia/lymphoma 2 (bcl2) anticorps
  • AW986256 anticorps
  • bcl-2 anticorps
  • Bcl2 anticorps
  • C430015F12Rik anticorps
  • D630044D05Rik anticorps
  • D830018M01Rik anticorps
  • PPP1R50 anticorps

Protein level used designations for BCL2

B-cell lymphoma protein 2 , B-cell leukemia/lymphoma 2 , apoptosis regulator Bcl-2 , B-cell CLL/lymphoma 2 , protein phosphatase 1, regulatory subunit 50 , B cell lymphoma 2 associated oncogene , Bcl2-like protein , BCL2B-cell CLL/lymphoma 2 , PCKBCL2 , Bcl2 , zBlp2

738409 Pan troglodytes
100224888 Taeniopygia guttata
12043 Mus musculus
100733337 Cavia porcellus
596 Homo sapiens
24224 Rattus norvegicus
403416 Canis lupus familiaris
493934 Felis catus
100049703 Sus scrofa
281020 Bos taurus
396282 Gallus gallus
100009447 Oryctolagus cuniculus
570772 Danio rerio
Fournisseurs de qualité sélectionnés pour anti-BCL2 (BCL2) Anticorps
Avez-vous cherché autre chose?